Clinica Baviera Stock Price To Earnings To Growth
| CBAV Stock | EUR 33.70 0.30 0.90% |
Clinica Baviera fundamentals help investors to digest information that contributes to Clinica Baviera's financial success or failures. It also enables traders to predict the movement of Clinica Stock. The fundamental analysis module provides a way to measure Clinica Baviera's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clinica Baviera stock.
Clinica |
Clinica Baviera Company Price To Earnings To Growth Analysis
Clinica Baviera's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Clinica Baviera has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Providers & Services sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all Spain stocks is 100.0% higher than that of the company.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Clinica Fundamentals
| Return On Equity | 0.47 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 301.63 M | |||
| Shares Outstanding | 16.3 M | |||
| Shares Owned By Insiders | 91.61 % | |||
| Shares Owned By Institutions | 6.79 % | |||
| Price To Earning | 20.23 X | |||
| Price To Book | 4.33 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 172.73 M | |||
| Gross Profit | 89.2 M | |||
| EBITDA | 52.91 M | |||
| Net Income | 27.39 M | |||
| Cash And Equivalents | 10.79 M | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 6.52 M | |||
| Debt To Equity | 154.20 % | |||
| Current Ratio | 0.91 X | |||
| Book Value Per Share | 4.27 X | |||
| Cash Flow From Operations | 46.86 M | |||
| Earnings Per Share | 1.82 X | |||
| Target Price | 24.3 | |||
| Number Of Employees | 722 | |||
| Beta | 0.51 | |||
| Market Capitalization | 308.14 M | |||
| Total Asset | 133.81 M | |||
| Z Score | 29.2 | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 4.03 % | |||
| Net Asset | 133.81 M | |||
| Last Dividend Paid | 1.03 |
About Clinica Baviera Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clinica Baviera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clinica Baviera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clinica Baviera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Clinica Stock
Clinica Baviera financial ratios help investors to determine whether Clinica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clinica with respect to the benefits of owning Clinica Baviera security.